Oct 14, 2021
Brii Biosciences Announces Upcoming Participation at November Conferences
Oct 09, 2021
Brii Bio Initiates Submission of Emergency Use Authorization Filing to U.S. FDA for BRII-196/BRII-198, its Monoclonal Antibody Combination Therapy for Non-Hospitalized COVID-19 Patients at High Risk
